Nitric oxide-angiotensin II interactions and renal hemodynamic function in patients with uncomplicated type 1 diabetes

American Journal of Physiology - Renal Physiology

Volumn 305, Issue 1, 2013, Pages

  Montanari, Alberto ^a   Pelà, Giovanna ^a   Musiari, Luisa ^a   Crocamo, Antonio ^a   Boeti, Luisella ^a   Cabassi, Aderville ^a   Biggi, Almerina ^a   Cherney, David Z ^b  

^a UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

L NAME; Losartan; Nitric oxide; Renal hemodynamic function; Renin angiotensin system; Type 1 diabetes mellitus

Indexed keywords

ANGIOTENSIN II; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM EXCRETION; UPREGULATION;

EID: 84879586792     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00109.2013     Document Type: Article

References (47)

1. Alberola AM, Salazar FJ, Nakamura T, Granger JP. Interaction between angiotensin II and nitric oxide in control of renal hemodynamics in conscious dogs. Am J Physiol Regul Integr Comp Physiol 267: R1472-R1478, 1994.
2. Barba G, Vallance PJ, Strazzullo P, MacAllister RJ. Effects of sodium intake on the pressor and renal responses to nitric oxide synthesis inhibition in normotensive individuals with different sodium sensitivity. J Hypertens 18: 615-621, 2000.
3. Baylis C, Harvey J, Engels K. Acute nitric oxide blockade amplifies the renal vasoconstrictor actions of angiotensin II. J Am Soc Nephrol 5: 211-214, 1994.
4. Baylis C, Harvey J, Santmyire BR, Engels K. Pressor and renal vasoconstrictor responses to acute systemic nitric oxide synthesis are independent of sympathetic nervous system and angiotensin II. J Pharmacol Exp Ther 288: 693-698, 1999.
5. Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol Renal Physiol 274: F914-F923, 1998.
6. Bech JN, Svendsen KB, Nielsen CB, Pedersen EB. The systemic and renal response to NO inhibition is not modified by angiotensin-II-receptor blockade in healthy humans. Nephrol Dial Transplant 14: 641-647, 1999.
7. Bell TD, DiBona GF, Biemiller R, Brands MW. Continuously measured renal blood flow does not increase in diabetes if nitric oxide synthesis is blocked. Am J Physiol Renal Physiol 295: F1449-F1456, 2008.
8. Brands MW, Bell TD, Gibson B. Nitric oxide may prevent hypertension early in diabetes by counteracting renal actions of superoxide. Hypertension 43: 57-63, 2004.
9. Boer WH, Koomans HA, Dorhout Mees EJ, Gaillard GA, Rabelink AJ. Lithium clearance during variations in sodium intake in man: effects of sodium restriction and amiloride. Eur J Clin Invest 18: 279-283, 1988.
10. Broere A, Van Den Meiracker AH, Boomsma F, Derkx FH, Manin T Veld AJ, Schalekamp AD. Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME. Am J Physiol Renal Physiol 275: F870-F877, 1998.
11. Cherney DZ, Sochett EB, Miller JA. Gender differences in renal responses to hyperglycemia and angiotensin-converting enzyme inhibition in diabetes. Kidney Int 68: 1722-1728, 2005.
12. Cherney DZI, Scholey JW, Miller JA. Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev 4: 280-290, 2008.
13. Cherney DZI, Reich HN, Jiang S, Har R, Nasrallah R, Hébert RL, Lai V, Scholey JW, Sochett EB. Hyperfiltration and the effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus. Am J Physiol Regul Integr Comp Physiol 303: R710-R718, 2012.
14. Chiarelli F, Cipollone F, Romano F, Tumini S, Costantini F, di Ricco L, Pomilio M, Pierdomenico SD, Marini M, Cuccurullo F, Mezzetti A. Increased circulating nitric oxide in young patients with type 1 diabetes and persistent microalbuminuria: relation to glomerular hyperfiltration. Diabetes 49: 1258-1263, 2000.
15. Davì G, Ciabattoni G, Consoli A, Mezzetti A, Falco A, Santarone S, Pennese E, Vitacolonna E, Bucciarelli T, Costantini F, Capani F, Patrono C. In vivo formation of 8-isoprostaglandin-f2 and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation 99: 224-229, 1999.
16. Delles C, Klingbeil AU, Schneider MP, Handrock R, Schäufele T, Schmieder RE. The role of nitric oxide in the regulation of glomerular haemodynamics in humans. Nephrol Dial Transplant 19: 1392-1397, 2004.
17. 3H] losartan across isolated perfused rabbit proximal tubule. J Pharmacol Exp Ther 290: 38-42, 1999.
18. Gandhi SK, Ryder DH, Brown NJ. Losartan blocks aldosterone and renal vascular responses to angiotensin II in humans. Hypertension 28: 961-966, 1996.
19. Granger JP, Alberola AM, Salazar FJ, Nakamura T. Control of renal hemodynamics during intrarenal and systemic blockade of nitric oxide synthesis in conscious dog. J Cardiovasc Pharmacol 20, Suppl 12: S160-S162, 1992.
20. Hannedouche TP, Delgado AG, Gnionsahe DA, Boitard C, Grunfeld JP. Renal hemodynamics and segmental tubular sodium reabsorption in early type 1 diabetes. Kidney Int 37: 1126-1133, 1990.
21. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens 11: 1375-1380, 1993.
22. Herrera M, Ortiz PA, Garvin JL. Regulation of thick ascending limb transport: role of nitric oxide. Am J Physiol Renal Physiol 290: F1279-F1284, 2006.
23. Hollenberg NK, Price DA, Fisher ND, Lansang MC, Perkins B, Gordon MS, Williams GH, Laffel LM. Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus. Kidney Int 63: 172-178, 2003.
24. Komers R, Oyama TT, Chapman JG, Allison KM, Anderson S. Effects of systemic inhibition of neuronal nitric oxide synthase in diabetic rats. Hypertension 34: 655-661, 2000.
25. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 284: F1121-F1137, 2003.
26. G-nitro-L-arginine methyl ester on renal function and blood pressure. Am J Physiol Renal Fluid Electrolyte Physiol 261: F1033-F1037, 1991.
27. Lansang MC, Hollenberg NK. Renal perfusion and the renal hemodynamic response to blocking the renin system in diabetes: Are the forces leading to vasodilation and vasoconstriction linked? Diabetes 51: 2025-2028, 2002.
28. Larsen T, Mose FH, Bech JN, Pedersen EB. Effect of nitric oxide inhibition on blood pressure and renal sodium handling: a dose-response study in healthy man. Clin Exp Hypertens 34: 567-574, 2012.
29. Llinas MT, Gonzales JD, Nava E, Salazar FJ. Role of angiotensin II in the renal effects induced by nitric oxide and prostaglandin synthesis inhibition. J Am Soc Nephrol 8: 543-550, 1997.
30. Lopez B, Salom MG, Arregui B, Valero F, Fenoy FJ. Role of superoxide in modulating the renal effects of angiotensin II. Hypertension 42: 1150-1156, 2003.
31. Majid DS, Nishiyama A, Jackson KE, Castillo A. Inhibition of nitric oxide synthase enhances superoxide activity in canine kidney. Am J Physiol Regul Integr Comp Physiol 287: R27-R32, 2004.
32. Miller JA. Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus. J Am Soc Nephrol 10: 1778-1785, 1999.
33. Montanari A, Tateo E, Fasoli E, Giberti D, Perinotto P, Novarini A, Dall'Aglio P. Angiotensin II blockade does not prevent renal effects of L-NAME in sodium-repleted humans. Hypertension 30: 557-562, 1997.
34. Montanari A, Biggi A, Carra N, Fasoli E, Calzolari M, Perinotto P, Novarini A. Selective endothelin-A blockade attenuates systemic and renal hemodynamic effects of L-NAME in humans. Hypertension 35: 518-523, 2000.
35. Montanari A, Carra N, Perinotto P, Iori V, Fasoli E, Biggi A, Novarini A. Renal hemodynamic control by endothelin and nitric oxide under angiotensin II blockade in man. Hypertension 39: 715-720, 2002.
36. Montanari A, Biggi A, Cabassi A, Pelloni I, Pigazzani F, Pinelli S, Pelà G, Musiari L, Cherney DZ. Renal hemodynamic response to L-arginine in uncomplicated, type 1 diabetes mellitus: the role of buffering anions and tubuloglomerular feedback. Am J Physiol Renal Physiol 303: F648-F658, 2012.
37. O'Byrne S, Forte P, Roberts LJII, Morrow JD, Johnston A, Anggard E, Leslie RD, Benjamin N. Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion. Diabetes 49: 857-862, 2000.
38. Perinotto P, Biggi A, Carra N, Orrico A, Valmadre G, Dall'Aglio P, Novarini A, Montanari A. Angiotensin II and prostaglandin interactions on systemic and renal effects of L-NAME in humans. J Am Soc Nephrol 12: 1706-1712, 2001.
39. Price DA, Porter LE, Gordon M, Fisher ND, De'Oliveira JM, Laffel LM, Passan DR, Williams GH, Hollenberg NK. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol 10: 2382-2391, 1999.
40. Schmitt F, Martinez F, Brillet G, Nguyen-Khoa T, Brouard R, Sissman J, Lacour B, Grunfeld JP. Acute renal effects of AT1-receptor blockade after exogenous angiotensin II infusion in healthy subjects. J Cardiovasc Pharmacol 31: 314-321, 1998.
41. Sigmon DH, Carretero OA, Beierwaltes WH. Angiotensin dependence of endothelium-mediated renal hemodynamics. Hypertension 20: 643-650, 1992.
42. Simonsen JA, Rasmussen MS, Johansen JB, Høilund-Carlsen PF, Bie P. Systemic nitric oxide clamping in normal humans guided by total peripheral resistance. Acta Physiol (Oxf) 198: 125-132, 2010.
43. Sochett EB, Cherney DZ, Curtis JR, Dekker MG, Scholey JW, Miller JA. Impact of renin angiotensin system modulation on the hyperfiltration state in type 1 diabetes. J Am Soc Nephrol 17: 1703-1709, 2006.
44. Süto T, Losonczy G, Qiu C, Hill C, Samsell Ruby J, Charon N, Venuto R, Baylis C. Acute changes in urinary excretion of nitrite and nitrate (UnoxV) do not predict vascular NO production. Kidney Int 48: 1272-1279, 1995.
45. Vallon V, Komers R. Pathophysiology of the diabetic kidney. Compr Physiol 1: 1175-1232, 2011.
46. van der Linde NA, van den Meiracker AH, Boomsma F. Role of angiotensin II in L-NAME-induced systemic and renal hemodynamic effects in hydrochlorothiazide-pretreated hypertensive subjects. J Hypertens 21: 345-351, 2003.
47. Wecht JM, Weir JP, Goldstein DS, Krothe-Petroff A, Spungen AM, Holmes C, Bauman WA. Direct and reflexive effects of nitric oxide synthase inhibition on blood pressure. Am J Physiol Heart Circ Physiol 294: H190-H197, 2008.